This appointment adds a scientific and medical expert to the board but carries no immediate trading signal. Monitor for any strategic shifts in R&D direction or upcoming pipeline catalysts.
Price Chart
Executive Summary
BioMarin appointed Robert Plenge, M.D., Ph.D., to its Board of Directors, expanding the board from ten to eleven members, and granted him $400,000 in restricted stock units. This is a routine director appointment with no material financial implications for the company.
Key Facts
- Board size increased from ten to eleven members with the appointment of Robert Plenge, M.D., Ph.D., effective September 10, 2026.
- Dr. Plenge was appointed to the Science and Technology Committee.
- He received a restricted stock unit grant valued at $400,000, vesting on the date prior to the next annual meeting.
- No departure of existing directors or C-suite executives is reported.
- Dr. Plenge was not selected pursuant to any arrangement with any person and has no reportable related-party transactions.
Financial Impact
Director appointment with a $400,000 RSU grant — immaterial relative to BioMarin's $12.7B market cap.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001628280-26-061717 |
| Document: 0001628280-26-061717-index-headers.html | 0001628280-26-061717 |
| Document: 0001628280-26-061717-index.html | 0001628280-26-061717 |
| Document: 0001628280-26-061717.txt | 0001628280-26-061717 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 15, 2026 17d ago | 8-K | $64.45 $63.94 | ▼ −0.79% | ▼ −1.61% | $57.18 (−11.28%) |
Sep 14, 2026 18d ago | 8-K | $66.41 $64.06 | ▼ −3.54% | ▼ −3.65% | $57.18 (−13.90%) |
Sep 1, 2026 4w ago | 8-K | $64.84 $64.41 | ▼ −0.66% | ▼ −0.74% | $57.18 (−11.81%) |
Sep 1, 2026 4w ago | Press Release | $64.84 $64.41 | ▼ −0.66% | ▼ −0.74% | $57.18 (−11.81%) |
Aug 31, 2026 4w ago | 8-K | $65.23 $64.63 | ▼ −0.92% | ▼ −0.78% | $57.18 (−12.34%) |
Aug 18, 2026 6w ago | 8-K | $66.99 $66.12 | ▼ −1.30% | ▼ −1.10% | $57.18 (−14.64%) |
Jun 4, 2026 17w ago | 8-K | $56.77 $55.95 | ▼ −1.44% | ▼ −2.01% | $57.18 (+0.72%) |
Apr 27, 2026 22w ago | 8-K | $53.62 $55.42 | ▲ +3.36% | ▲ +2.96% | $57.18 (+6.63%) |
Apr 21, 2026 23w ago | DEFA14A | $54.16 $53.24 | ▼ −1.71% | ▼ −1.76% | $57.18 (+5.57%) |
Feb 28, 2026 30w ago | Institutional Cluster | $59.71 $60.65 | ▲ +1.57% | ▲ +2.78% | $57.18 (−4.24%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access